Main Session
Sep
29
PQA 06 - PQA 06: Genitourinary Cancer, Gynecological Cancer, and Health Care Access and Engagement
3388 - A Phase II Trial In Progress: Alpha-emitting radioNucliDe or Beta-Emitting RadiOnuclide Combined With MEtastasis-Directed Stereotactic Body Radiotherapy for Oligorecurrent Prostate Adenocarcinoma (ANDROMEDA)<sup></sup>
Presenter(s)
Kekoa Taparra, MD, PhD, MPH - UCLA Health, Los Angeles, CA